Financials
- Market Capitalization 267.6 M
- Employee 293
- Founded 2000
- CEO N/A
- Website www.macrogenics.com
- Headquarter Delaware, United States
- FIGI BBG000BM2SF8
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-2.6
ratio cours/chiffre d'affaires
1.16
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3396 | GLSI Greenwich LifeSciences, Inc. - Common stock | 19.01 USD | 0.00% | +2.15% | -17.49% | +87.66% | 279.03 M USD | ||
| 3404 | SABS SAB Biotherapeutics, Inc. - Common Stock | 3.54 USD | -1.67% | -8.76% | -9.23% | +26.43% | 270.68 M USD | ||
| 3414 | IKT Inhibikase Therapeutics, Inc. - Common Stock | 2.07 USD | +0.49% | -0.48% | +23.95% | +15.00% | 273.31 M USD | ||
| 3419 | ALXO ALX Oncology Holdings Inc. - Common Stock | 1.96 USD | -2.00% | -17.30% | +23.27% | +317.02% | 263.74 M USD |